Abbott Laboratories has received FDA approval to market acombination test for simultaneous detection of antibodies to HIV-1and HIV-2, the company said Friday.

The Abbott Park, Ill., company's combination test is the secondapproved by the FDA, which last September approved an enzymeimmunoassay (ELISA) test produced by Genetic Systems Corp.

According to Abbott (NYSE:ABT), the FDA intends to require bloodbanks to test their supplies for HIV-2 beginning June 1.

(c) 1997 American Health Consultants. All rights reserved.